Small Molecules

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

An AI platform seeks out drugs that can be repurposed to treat COVID-19.

A position paper outlines why manufacturers must improve data integrity for excipients.

Is stencil printing a viable approach to create flexible dosage forms?

Can the USA boost its manufacturing capacity for critical drugs?

How is the business of making medicine changing in light of the COVID-19 pandemic?

How can nanotechnology be used to deliver drugs through the skin?

Sitting Down With… Paul Peter Tak, President and CEO at Kintai Therapeutics.

We speak with Richard Bourne about his work on pharmaceutical processes.

We’re moving towards a data-driven future of enhanced manufacturing. And we must lay the foundations today.